Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
113 studies found for:    "Hyperadrenalism"
Show Display Options
Rank Status Study
1 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
2 Recruiting Hypercortisolism and Epicardial Adipose Tissue
Condition: Hypercortisolism
Interventions: Biological: Blood samples for measuring adiponectin, leptin and omentin plasma;   Device: MRI at 3 Tesla
3 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Interventions: Procedure: Adrenalectomy;   Other: Observation
4 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
5 Completed Heart Disease Risk Factors in Major Depression
Conditions: Adrenal Gland Hyperfunction;   Cardiovascular Disease;   Involutional Depression
Intervention:
6 Completed Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
Conditions: Adrenal Gland Hyperfunction;   Adrenal Gland Hypofunction;   Cushing's Syndrome;   Healthy
Intervention: Drug: Ovine Corticotropin-Releasing Hormone (oCRH)
7 Terminated A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition: Cushing's Syndrome
Intervention: Drug: Cushing's syndrome confirmation
8 Recruiting Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease
Conditions: Alzheimer Disease;   Oxidative Stress;   Adrenocortical Hyperfunction
Intervention:
9 Unknown  Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
10 Withdrawn Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: NBI-77860
11 Recruiting Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
Condition: Cushing Syndrome
Intervention: Procedure: surgery
12 Active, not recruiting Diagnostic Performance of Screening Tests for Cushing s Syndrome
Condition: Cushing's Syndrome
Intervention:
13 Not yet recruiting Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: CORT125134
14 Completed
Has Results
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
15 Completed
Has Results
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
16 Recruiting Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Conditions: Cushing's Syndrome;   Adrenal Incidentalomas;   Alcoholism;   Obesity
Intervention:
17 Recruiting A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: ATR-101
18 Not yet recruiting Prenatal Dex Study
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Neuropsychological and cognitive assessment
19 Recruiting Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Drug: Chronocort®;   Drug: standard glucocorticoid therapy
20 Not yet recruiting Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Abiraterone acetate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years